Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group

Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group

Item

http://www.wikidata.org/entity/Q33980144

Q33980144

about

Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults Canadian practice guidelines for surgical intra-abdominal infections Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Antibiotic stewardship in the intensive care unit.Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials Incidence and impact on clinical outcome of infections with piperacillin/tazobactam resistant Escherichia coli in ICU: a retrospective study.Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis.Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study.Combination therapy for treatment of infections with gram-negative bacteria.Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.Antibiotic prescription patterns in the empiric therapy of severe sepsis: combination of antimicrobials with different mechanisms of action reduces mortality.Antimicrobial treatment for intra-abdominal infections.Compliance with an empirical antimicrobial protocol improves the outcome of complicated intra-abdominal infections: a prospective observational study Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis.Overview of antimicrobial therapy in intensive care units.Shortening the course of antibiotic treatment in the intensive care unit.Aminoglycoside use in a pediatric hospital: there is room for improvement-a before/after study.Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care.Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).Are enterococci playing a role in postoperative peritonitis in critically ill patients?

P2860

Q24201201-13CBEC34-696E-46E0-AF37-F5063A25B6DE Q24244685-A244FA0C-6492-4CB2-92CE-758809FE6ECF Q24246927-158077C0-3AFB-4427-8270-0DBF440517A5 Q24599288-1026A6FB-B868-448D-98D3-E79D7F9778B4 Q26739860-75B4A514-C14A-4015-B98E-943995315B2C Q30408712-E11D78DF-8690-4AE8-AB14-2D5DBB0FAF9C Q30756968-0DB2F295-1EAB-48E1-ABAC-5573A022C997 Q33335393-41F5FC16-CD26-4C0F-B309-72C6F9A506BB Q33873475-BA23647F-7837-435B-A55F-5779FF6EFD5E Q34128899-32B120E7-7E5D-4CCB-8910-73D75DF5560A Q35654012-9B3D1B62-3316-4770-A2C1-5A8A990FB53B Q36156077-BEDB5781-E22E-4975-A8D7-16870CD18648 Q36839703-6EA4DB82-8181-46DB-B0AF-C07887600301 Q36902771-2BCFDDB1-1B49-4E03-80F0-6391B24CC3F6 Q37000729-862699DF-F439-4CCC-ABAE-B3AFC0433137 Q37019657-5C133EF1-AAB4-42EE-BAE4-953B9A7BB11C Q37279923-16FA4608-6E05-4CEF-AE29-F9367A8FE106 Q37822457-4D3F0E10-35F4-4357-B97E-F5E254483DF0 Q38341882-BE865A72-D298-426F-A82D-64D9EEE0962D Q40081223-BAE41F8B-45D6-4417-B840-4255DB84FC1C Q43223068-C4C0AFEB-FE93-47AB-BA76-652E70CBB185 Q44526972-E0DDF129-B755-47BF-8EEB-070708CC978E Q45031561-3B3A3C73-96C7-44DA-AE25-D239CF0982C8

P2860

Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group

Item

http://www.wikidata.org/entity/Q33980144

description

2000 nî lūn-bûn

@nan

2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu